{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/metlife-met/",
 "dataUrl": "https://clearank.com/stock/metlife-met/data.json",
 "title": "MetLife Inc (MET) Stock Forecast & Price Target (2026)",
 "description": "MetLife, Inc. (MET) stock: Financial Services, Insurance - Life. $62.1B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "MetLife, Inc. (MET)",
 "published": "2026-07-17T09:31:41+00:00",
 "modified": "2026-09-27T02:16:19.166+00:00",
 "generated": "2026-09-27T15:06:46.490Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "MET",
  "name": "MetLife, Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Financial Services",
  "industry": "Insurance - Life",
  "country": "United States",
  "website": "https://www.metlife.com"
 },
 "quote": {
  "price": 97.7,
  "previousClose": 97.25,
  "change": 0.45,
  "changePercent": 0.46,
  "open": 97.54,
  "high": 98.45,
  "low": 96.67,
  "volume": 3625300,
  "averageVolume": 3325290,
  "marketCap": 62086095767,
  "fiftyTwoWeekHigh": 100.93,
  "fiftyTwoWeekLow": 67.33,
  "marketOpen": false,
  "asOf": "2026-09-27T02:16:19.000Z"
 },
 "statistics": {
  "pe": 18.716475,
  "eps": 5.22,
  "dividendYield": 0.02427840403369303,
  "beta": 0.759,
  "priceToSales": 0.7819604,
  "priceToBook": 2.2706144,
  "revenueTtm": 79398002688,
  "grossMargin": null,
  "returnOnEquity": 0.13094
 },
 "technicals": {
  "rsi": 50.44,
  "macd": 0.41,
  "sma50": 96.28,
  "sma200": 83.4,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 72,
  "consensus": "Buy",
  "fairValue": 108,
  "analystTarget": 108,
  "analystCount": 18,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-27T02:16:19.000Z",
  "priceAtAnalysis": 97.7,
  "volatility": {
   "daily": 1.19,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 95.75,
  "aggressiveEntry": 97.7,
  "stopLoss": 92.87,
  "stopLossPercent": 3,
  "targets": [
   100.53,
   105.32,
   110.11
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 72.04,
    "base": 105.94,
    "upside90th": 155.77
   },
   {
    "year": 2028,
    "downside10th": 66.58,
    "base": 114.86,
    "upside90th": 198.15
   },
   {
    "year": 2029,
    "downside10th": 63.87,
    "base": 124.55,
    "upside90th": 242.86
   },
   {
    "year": 2030,
    "downside10th": 62.46,
    "base": 135.04,
    "upside90th": 292
   },
   {
    "year": 2031,
    "downside10th": 61.83,
    "base": 146.43,
    "upside90th": 346.78
   },
   {
    "year": 2032,
    "downside10th": 61.74,
    "base": 158.77,
    "upside90th": 408.26
   },
   {
    "year": 2033,
    "downside10th": 62.07,
    "base": 172.15,
    "upside90th": 477.47
   },
   {
    "year": 2034,
    "downside10th": 62.72,
    "base": 186.66,
    "upside90th": 555.49
   },
   {
    "year": 2035,
    "downside10th": 63.66,
    "base": 202.4,
    "upside90th": 643.51
   },
   {
    "year": 2036,
    "downside10th": 64.84,
    "base": 219.46,
    "upside90th": 742.8
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "MET Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$97.54",
    "Day Range": "$96.67 to $98.45",
    "Prev Close": "$97.25",
    "Volume": "3.63M",
    "52-Week Range": "$67.33 to $100.93",
    "Market Cap": "$62.09B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Valuation is broadly in line with sector peers (13% difference), suggesting fair market pricing relative to industry standards."
   ]
  },
  {
   "id": "financials",
   "title": "MET Financial Performance",
   "text": [
    "Analysis: In the last 4 quarters, MET beat estimates 4 times. However, the stock fell 2 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "MET Analysis",
   "text": [
    "MetLife, Inc. (MET) exhibits neutral momentum with its Relative Strength Index (RSI) at 50.44, indicating neither overbought nor oversold conditions. The stock is trading above its 50-day and 200-day moving averages ($96.28 and $83.40), as well as its 20-day exponential moving average ($96.84), suggesting an overall upward trend. The Moving Average Convergence Divergence (MACD) is currently positive at 0.41, reinforcing the bullish short-term trend. Key support levels are found near the 50-day SMA at $96.28, with resistance potentially emerging around the $100 mark and the upper end of the analyst target range. Trading volume has been slightly above its average, with the latest volume at 3.63 million compared to an average of 3.33 million, indicating healthy investor interest. The current chart structure suggests continued stability with potential for upward movement if key resistance levels are breached.",
    "MetLife has a strong track record of exceeding EPS estimates, with the latest quarter to June 2026 showing a 6.11% beat, driving positive stock performance.",
    "Analysts project strong EPS growth of 11.97% for the current year and 10.6% for the next year, indicating strong future earnings potential.",
    "The stock is trading above its 50-day and 200-day moving averages ($96.28 and $83.40), indicating positive technical momentum and potential for further price appreciation.",
    "Insiders have sold $3.8 million worth of stock, signaling a moderate sell-off, although attributed to corporate restructuring.",
    "Revenue is estimated to decrease by 15.00% year-over-year in the next quarter, potentially indicating short-term headwinds.",
    "MetLife, Inc. (MET) is expected to maintain its positive trajectory, with analysts projecting current year EPS growth of 11.97% and next year growth of 10.6%. The median price target of $108.00 suggests a potential upside of 10.5% from the current price of $97.70, supported by a strong Buy consensus from 18 analysts. The company's consistent earnings beats and above-average revenue growth estimates for the current year provide a solid foundation for this outlook. Key catalysts for upside include continued strong performance in its insurance and annuity segments, potential for further margin expansion, and favorable interest rate environments. Downside risks include a projected revenue decline of 15.00% in the next quarter, increased competition, and potential regulatory changes within the financial services sector. Insider selling, though moderate and attributed to restructuring, warrants monitoring."
   ],
   "lists": {
    "ProTips": [
     "Monitor the projected revenue decline in the next quarter for any signs of further weakness or stabilization.",
     "MetLife's dividend yield of approximately 2.38% may appeal to income-focused investors, but consider the moderate insider selling signal.",
     "As a large-cap insurer, MetLife's performance is sensitive to interest rate movements and regulatory environments. Stay informed on macroeconomic trends and policy changes."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Consistent Earnings Beats",
     "text": "MetLife has a strong track record of exceeding EPS estimates, with the latest quarter to June 2026 showing a 6.11% beat, driving positive stock performance.",
     "source": "Earnings Reports"
    },
    {
     "type": "Bullish",
     "title": "Positive Forward Growth Estimates",
     "text": "Analysts project strong EPS growth of 11.97% for the current year and 10.6% for the next year, indicating strong future earnings potential.",
     "source": "Wall Street Estimates"
    },
    {
     "type": "Bullish",
     "title": "Above Key Moving Averages",
     "text": "The stock is trading above its 50-day and 200-day moving averages ($96.28 and $83.40), indicating positive technical momentum and potential for further price appreciation.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bearish",
     "title": "Moderate Insider Selling",
     "text": "Insiders have sold $3.8 million worth of stock, signaling a moderate sell-off, although attributed to corporate restructuring.",
     "source": "Insider Transactions"
    },
    {
     "type": "Bearish",
     "title": "Projected Next Quarter Revenue Decline",
     "text": "Revenue is estimated to decrease by 15.00% year-over-year in the next quarter, potentially indicating short-term headwinds.",
     "source": "Wall Street Estimates"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "MetLife, Inc. (MET) presents a mixed valuation picture, trading at a P/E ratio of 18.72, which is above the Financial Services sector median of 16.5, but its price-to-sales ratio of 0.78 is well below the sector median of 3.8. The company's return on equity (ROE) of 13.09% is closely aligned with the sector average of 13.8%, indicating comparable profitability efficiency. Growth prospects appear solid, with projected current year revenue growth of 1.00% and next year growth of 5.00%, alongside an estimated current year EPS growth of 11.97%. The company's profit margin of 4.57% and operating margin of 5.52% are respectable within its industry. However, its debt-to-equity ratio of 1.80 is higher than the sector average of 1.8, suggesting a more leveraged balance sheet. Despite this, the consistent earnings beats and positive forward estimates provide a foundation for its current valuation.",
    "MetLife, Inc. (MET) has demonstrated a consistent pattern of exceeding analyst expectations in its recent quarterly earnings reports. The most recent quarter to June 2026 saw actual EPS of $2.43, surpassing the estimate of $2.29 by 6.11% and leading to a 3.83% increase in stock price. Prior quarters also show positive surprises, including a 9.74% beat in the quarter to June 2026 (reported July 27) and a 6.61% beat in the quarter to March 2026. This track record of earnings performance suggests strong operational execution and effective financial management.",
    "MetLife, Inc. (MET) faces moderate risks stemming from its insider sentiment, which shows a net selling signal with $3.8 million in sales, although this is attributed to corporate restructuring. The company's debt-to-equity ratio of 1.80 is higher than the sector average, indicating increased financial leverage. Additionally, while revenue growth is positive, the projected -15.00% year-over-year change for the next quarter could signal short-term headwinds or seasonality within the insurance industry."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "62.09B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "18.72"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "5.22"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "2.38%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "100.93"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "67.33"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Neutral SMA Cross Bullish Price vs SMA Bullish MACD Bullish Golden Cross in effect with the 50-day SMA ($96.28) above the 200-day SMA ($83.40), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "50.44"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "0.41"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "96.28"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "83.40"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.61",
    "Correlation with Nasdaq 100 (QQQ)": "+0.45",
    "Correlation with Bitcoin (BTC)": "+0.17",
    "Correlation with Gold (XAU)": "+0.00"
   }
  },
  {
   "id": "trade-plans",
   "title": "MET Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (50.4) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$100.53",
    "TARGET 2": "$105.32",
    "TARGET 3": "$110.11",
    "STOP LOSS": "$92.87"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+2.06%",
    "Average Feb return": "-0.83%",
    "Average Mar return": "-5.12%",
    "Average Apr return": "+4.27%",
    "Average May return": "-0.85%",
    "Average Jun return": "+0.60%",
    "Average Jul return": "+2.59%",
    "Average Aug return": "+1.69%",
    "Average Sep return": "+1.76%",
    "Average Oct return": "+0.79%",
    "Average Nov return": "+5.89%",
    "Average Dec return": "-0.97%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.19%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in MET in September 2016 would be worth about $25,056 today, compared with about $35,782 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MET today could grow to about $22,462 by 2036 in the base case, with a bull case near $76,029 and a bear case around $6,636. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "MET Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $135 for MET by 2030 in the base case, from $97.70 today (1.4x over 4 years). The downside path ends near $62.46. These are outcomes of a Monte Carlo simulation run on MET's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using MET's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "MET simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$72.04",
        "$106",
        "$156"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$66.58",
        "$115",
        "$198"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$63.87",
        "$125",
        "$243"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$62.46",
        "$135",
        "$292"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$61.83",
        "$146",
        "$347"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$61.74",
        "$159",
        "$408"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$62.07",
        "$172",
        "$477"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$62.72",
        "$187",
        "$555"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$63.66",
        "$202",
        "$644"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$64.84",
        "$219",
        "$743"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "PNC The PNC Financial Services Group, Inc. NYSE $225.64 +1.03%",
     "url": "https://clearank.com/stock/pnc-financial-pnc/"
    },
    {
     "text": "SOFI SoFi Technologies, Inc. NASDAQ $16.58 -1.31%",
     "url": "https://clearank.com/stock/sofi-technologies-sofi/"
    },
    {
     "text": "MCO Moody's Corporation NYSE $468.70 +0.29%",
     "url": "https://clearank.com/stock/mco-stock-analysis/"
    },
    {
     "text": "RIOT Riot Platforms, Inc. NASDAQ $23.00 -2.04%",
     "url": "https://clearank.com/stock/riot-stock-analysis/"
    },
    {
     "text": "HBAN Huntington Bancshares Incorporated NASDAQ $15.64 +2.16%",
     "url": "https://clearank.com/stock/hban-stock-analysis/"
    },
    {
     "text": "PRU Prudential Financial, Inc. NYSE $119.45 +0.59%",
     "url": "https://clearank.com/stock/prudential-financial-pru/"
    },
    {
     "text": "UPST Upstart Holdings Inc. NASDAQ $23.81 -3.37%",
     "url": "https://clearank.com/stock/upstart-holdings-upst/"
    },
    {
     "text": "MTB M&T Bank Corporation NYSE $221.19 +1.16%",
     "url": "https://clearank.com/stock/mtb-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "F vs GM Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/f-vs-gm/"
    },
    {
     "text": "VOO vs VOOG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/voo-vs-voog/"
    },
    {
     "text": "GLD vs IAU Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/gld-vs-iau/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "MET Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$3.8M",
    "Insiders": "23",
    "Avg Transaction": "$1.9M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in MET",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Dec 12, 2022",
       "cells": [
        "KHALAF MICHEL Chief Executive Officer",
        "Sell",
        "57.2K",
        "$4.1M"
       ]
      },
      {
       "label": "Feb 8, 2022",
       "cells": [
        "GOULART STEVEN J Chief Investment Officer",
        "Sell",
        "56.9K",
        "$4.0M"
       ]
      },
      {
       "label": "Dec 21, 2021",
       "cells": [
        "KHALAF MICHEL Chief Executive Officer",
        "Sell",
        "42.7K",
        "$2.6M"
       ]
      },
      {
       "label": "Dec 12, 2022",
       "cells": [
        "GOULART STEVEN J Chief Investment Officer",
        "Sell",
        "29.4K",
        "$2.1M"
       ]
      },
      {
       "label": "May 12, 2025",
       "cells": [
        "PAPPAS BILL Officer",
        "Sell",
        "26.0K",
        "$2.1M"
       ]
      },
      {
       "label": "Mar 18, 2024",
       "cells": [
        "PAPPAS BILL Officer",
        "Sell",
        "27.0K",
        "$2.0M"
       ]
      },
      {
       "label": "Dec 13, 2024",
       "cells": [
        "DEBEL MARLENE Officer",
        "Sell",
        "22.8K",
        "$1.9M"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "DEBEL MARLENE Officer",
        "Sell",
        "21.3K",
        "$1.7M"
       ]
      },
      {
       "label": "Dec 13, 2024",
       "cells": [
        "KHALAF MICHEL Chief Executive Officer",
        "Sell",
        "20.9K",
        "$1.7M"
       ]
      },
      {
       "label": "Feb 5, 2024",
       "cells": [
        "KHALAF MICHEL Chief Executive Officer",
        "Sell",
        "20.5K",
        "$1.3M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=MetLife%2C+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is MetLife's stock forecast for 2030?",
   "answer": "MetLife's stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $135.04, with a downside scenario at $62.46 and an upside scenario at $292. These are statistical outcomes, not guarantees."
  },
  {
   "question": "Is MetLife, Inc. stock a buy right now?",
   "answer": "MetLife, Inc. (MET) is currently rated as a Buy by Wall Street analysts, with a median price target of $108.00, suggesting a 10.5% upside from its current price of $97.70. The stock is trading above key moving averages and has a history of earnings beats."
  },
  {
   "question": "What are the key technical indicators for MetLife stock?",
   "answer": "MetLife's RSI is neutral at 50.44, and it is trading above its 50-day and 200-day moving averages ($96.28 and $83.40), indicating positive momentum. The MACD is also positive, reinforcing a bullish short-term trend."
  },
  {
   "question": "How does MetLife's financial health compare to its peers?",
   "answer": "MetLife's ROE of 13.09% is in line with the sector average of 13.8%, but its debt-to-equity ratio of 1.80 is slightly higher than the sector median. Its P/E ratio of 18.72 is above the sector median, while its P/S ratio of 0.78 is below."
  },
  {
   "question": "What is the recent insider trading activity for MetLife?",
   "answer": "Insider activity for MetLife shows a moderate sell signal, with $29.8M in total sales versus $0 in total purchases in recent filings. This is attributed to corporate restructuring rather than a lack of confidence."
  },
  {
   "question": "What are the growth prospects for MetLife?",
   "answer": "MetLife is projected to achieve current year EPS growth of 11.97% and next year EPS growth of 10.6%. Revenue growth is estimated at 1.00% for the current year and 5.00% for the next year."
  },
  {
   "question": "What is MetLife's dividend yield?",
   "answer": "MetLife, Inc. offers a dividend yield of approximately 2.38%, with a dividend rate of $2.32."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "PNC",
    "name": "The PNC Financial Services Group, Inc. NYSE",
    "price": "$225.64",
    "change": "+1.03%",
    "url": "https://clearank.com/stock/pnc-financial-pnc/"
   },
   {
    "ticker": "SOFI",
    "name": "SoFi Technologies, Inc. NASDAQ",
    "price": "$16.58",
    "change": "-1.31%",
    "url": "https://clearank.com/stock/sofi-technologies-sofi/"
   },
   {
    "ticker": "MCO",
    "name": "Moody's Corporation NYSE",
    "price": "$468.70",
    "change": "+0.29%",
    "url": "https://clearank.com/stock/mco-stock-analysis/"
   },
   {
    "ticker": "RIOT",
    "name": "Riot Platforms, Inc. NASDAQ",
    "price": "$23.00",
    "change": "-2.04%",
    "url": "https://clearank.com/stock/riot-stock-analysis/"
   },
   {
    "ticker": "HBAN",
    "name": "Huntington Bancshares Incorporated NASDAQ",
    "price": "$15.64",
    "change": "+2.16%",
    "url": "https://clearank.com/stock/hban-stock-analysis/"
   },
   {
    "ticker": "PRU",
    "name": "Prudential Financial, Inc. NYSE",
    "price": "$119.45",
    "change": "+0.59%",
    "url": "https://clearank.com/stock/prudential-financial-pru/"
   },
   {
    "ticker": "UPST",
    "name": "Upstart Holdings Inc. NASDAQ",
    "price": "$23.81",
    "change": "-3.37%",
    "url": "https://clearank.com/stock/upstart-holdings-upst/"
   },
   {
    "ticker": "MTB",
    "name": "M&T Bank Corporation NYSE",
    "price": "$221.19",
    "change": "+1.16%",
    "url": "https://clearank.com/stock/mtb-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "F vs GM Comparison",
    "name": "",
    "url": "https://clearank.com/compare/f-vs-gm/"
   },
   {
    "ticker": "VOO vs VOOG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/voo-vs-voog/"
   },
   {
    "ticker": "GLD vs IAU Comparison",
    "name": "",
    "url": "https://clearank.com/compare/gld-vs-iau/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Financial Services →",
   "url": "https://clearank.com/sector/financial-services/"
  },
  "Newly Tracked": [
   {
    "ticker": "SLVR",
    "text": "Sprott Silver Miners & Physical Silver ETF",
    "url": "https://clearank.com/etf/slvr-etf-analysis/"
   },
   {
    "ticker": "BRO",
    "text": "Brown & Brown Inc",
    "url": "https://clearank.com/stock/bro-stock-analysis/"
   },
   {
    "ticker": "SYY",
    "text": "Sysco Corp.",
    "url": "https://clearank.com/stock/syy-stock-analysis/"
   },
   {
    "ticker": "FIS",
    "text": "Fidelity National Information Services, Inc.",
    "url": "https://clearank.com/stock/fis-stock-analysis/"
   },
   {
    "ticker": "EXC",
    "text": "Exelon Corp.",
    "url": "https://clearank.com/stock/exc-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "ETHFI/USD",
    "text": "↓ 13.68%",
    "url": "https://clearank.com/crypto/ethfi-usd-crypto-analysis/"
   },
   {
    "ticker": "TON/USD",
    "text": "↑ 12.10%",
    "url": "https://clearank.com/crypto/toncoin-ton-usd/"
   },
   {
    "ticker": "SUI/USD",
    "text": "↑ 11.97%",
    "url": "https://clearank.com/crypto/sui-sui-usd/"
   },
   {
    "ticker": "KAS/USD",
    "text": "↑ 11.85%",
    "url": "https://clearank.com/crypto/kaspa-kas-usd/"
   },
   {
    "ticker": "RENDER/USD",
    "text": "↑ 10.19%",
    "url": "https://clearank.com/crypto/render-render-usd/"
   }
  ],
  "Also in Financial Services": [
   {
    "ticker": "AFL",
    "text": "Aflac Inc",
    "url": "https://clearank.com/stock/aflac-afl/"
   },
   {
    "ticker": "MCO",
    "text": "Moody’s Corporation",
    "url": "https://clearank.com/stock/mco-stock-analysis/"
   },
   {
    "ticker": "MKTX",
    "text": "MarketAxess",
    "url": "https://clearank.com/stock/mktx-stock-analysis/"
   },
   {
    "ticker": "MMC",
    "text": "Marsh & McLennan Companies, Inc.",
    "url": "https://clearank.com/stock/mmc-stock-analysis/"
   },
   {
    "ticker": "PRU",
    "text": "Prudential",
    "url": "https://clearank.com/stock/prudential-financial-pru/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/MET-metlife-met-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/MET-metlife-met-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "MetLife (MET) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/metlife-met/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/metlife-met/",
        "name": "MetLife Inc (MET) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/metlife-met/#webpage",
     "url": "https://clearank.com/stock/metlife-met/",
     "name": "MetLife Inc (MET) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-17T09:31:41+00:00",
     "dateModified": "2026-09-27T02:16:19+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/MET-metlife-met-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/metlife-met/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/metlife-met/#richSnippet",
     "headline": "MetLife Inc (MET) Stock Forecast & Price Target (2026)",
     "name": "MetLife Inc (MET) Stock Forecast & Price Target (2026)",
     "description": "MetLife, Inc. (MET) stock: Financial Services, Insurance - Life. $62.1B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-07-17T09:31:41+00:00",
     "dateModified": "2026-09-27T02:16:19+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "MetLife, Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "MET"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "MetLife, Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers. Its business spans group life, dental, disability, vision, accident and health coverage, along with retirement and inc",
      "tickerSymbol": "MET",
      "sameAs": "https://www.metlife.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/metlife-met/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/MET-metlife-met-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/metlife-met/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is MetLife's stock forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MetLife's stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $135.04, with a downside scenario at $62.46 and an upside scenario at $292. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "Is MetLife, Inc. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MetLife, Inc. (MET) is currently rated as a Buy by Wall Street analysts, with a median price target of $108.00, suggesting a 10.5% upside from its current price of $97.70. The stock is trading above key moving averages and has a history of earnings beats."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key technical indicators for MetLife stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MetLife's RSI is neutral at 50.44, and it is trading above its 50-day and 200-day SMAs, indicating positive momentum. The MACD is also positive, reinforcing a bullish short-term trend."
     }
    },
    {
     "@type": "Question",
     "name": "How does MetLife's financial health compare to its peers?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MetLife's ROE of 13.09% is in line with the sector average of 13.8%, but its debt-to-equity ratio of 1.80 is slightly higher than the sector median. Its P/E ratio of 18.72 is above the sector median, while its P/S ratio of 0.78 is below."
     }
    },
    {
     "@type": "Question",
     "name": "What is the recent insider trading activity for MetLife?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insider activity for MetLife shows a moderate sell signal, with $3.8 million in total sales versus $0 in purchases across 128 transactions. This is attributed to corporate restructuring rather than a lack of confidence."
     }
    },
    {
     "@type": "Question",
     "name": "What are the growth prospects for MetLife?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MetLife is projected to achieve current year EPS growth of 11.97% and next year EPS growth of 10.6%. Revenue growth is estimated at 1.00% for the current year and 5.00% for the next year."
     }
    },
    {
     "@type": "Question",
     "name": "What is MetLife's dividend yield?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MetLife, Inc. offers a dividend yield of approximately 2.38%, with a dividend rate of $2.32."
     }
    }
   ]
  }
 ]
}